A high proportion among the 44 reported cases affected...
drug regulator
Four issues together describe a latent crisis waiting under...
Bharat Biotech will have to continue the phase-3 clinical...
Bharat Biotech is awaiting approval of its regulatory documentation...
Britain is auditing manufacturing processes at Serum Institute of...
The drug regulator found the plant hadn’t taken the...
